Spinal Muscular Atrophy Conference a Success in 2009

April 30, 2009 - PRLog -- (Richmond, VA) -- The 2009 version of “The Good Fight”, Fight SMA’s Annual Conference, wrapped up on Tuesday, and it was another successful year! Here are a few of the highlights:

*20 researchers and two additional graduate students from the National Institute of Neurological Disorders and Stroke (NINDS) were in attendance.

*Three of the attending scientists joined five additional doctors and healthcare professionals in an educational panel for attendees of the “Families and Friends Conference.” This year’s panelists were Thomas Crawford, M.D., Tina Duong, MPT, Craig P. Eberson, M.D., Sally Evans, M.D., Sarah Feasel, MEd, RD, LD, CNSC, Mary Schroth, M.D., Kathy Swoboda, M.D., and Alex MacKenzie, M.D., Ph.D.

*On April 28, many of the families, friends and researchers descended on Capitol Hill to advocate for Spinal Muscular Atrophy and the SMA Treatment Acceleration Act, visiting the offices of more than 65 Congressional Representatives. After a productive day, the SMA community was thrilled to learn that HR 2149, the SMA Treatment Acceleration Act, had been re-introduced in the House of Representatives. FightSMA thanks all of our families, friends and researchers for kicking off the 2009 advocacy efforts in a big way.

*For the first year, Fight SMA offered a webinar of the Families and Friends panels. The webinar was a success, with 30 participants from 13 U.S. states and a total of four countries. Those who utilized the webinar said the experience was great!

Fight SMA is thankful for the contributions of everyone who made this conference a success, and for our sponsors, who made it possible: PTC Therapeutics, Genzyme, Hill-Rom Company, ISIS Pharmaceuticals, Psychogenics, Permobil, The Medi-Kid Co., and Exceptional Parent Magazine. A special “thank you” goes to Hill-Rom Company and Genzyme, which not only sponsored the event, but also sent representatives to attend the Families and Friends Conference!

About Fight SMA
FightSMA is a 501c3 nonprofit corporation, organized in 1991 to strategically accelerate research for a treatment and a cure for spinal muscular atrophy (SMA), the leading genetic cause of infant death. For more information, please visit http://www.fightsma.org.